Allergan Inc
AGN
AGN was delisted on the 16th of March, 2015.
8 hedge funds and large institutions have $11.1M invested in Allergan Inc in 2018 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 2 closing their positions.
200% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 1
11% less funds holding
Funds holding: 9 → 8 (-1)
15% less capital invested
Capital invested by funds: $13.1M → $11.1M (-$1.98M)
50% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCA
STALEY CAPITAL ADVISERS
Pittsburgh,
Pennsylvania
|
+$233K |
| 2 |
GIM
Grassi Investment Management
Santa Clara,
California
|
+$167K |
| 3 |
CA
Callahan Advisors
Houston,
Texas
|
+$11.7K |
| 4 |
GAM
Gemmer Asset Management
Walnut Creek,
California
|
+$2.73K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FIM
Frontier Investment Management
Dallas,
Texas
|
-$2.29M |
| 2 |
ARMC
American Research & Management Company
Marion,
Massachusetts
|
-$6K |
| 3 |
MMPW
Mitchell McLeod Pugh & Williams
Mobile,
Alabama
|
-$5K |
AGN Hedge Fund Activity: Q2 2018 in Review
8 of the 4,369 institutional investors tracked by Wall St. Rank reported a position in Allergan Inc (AGN) for Q2 2018, worth a combined $11.1M — down 15% from $13.1M a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of AGN and 1 opened new positions — a net loss of 1 holder — while 1 trimmed existing stakes and 3 added.
The largest buyer was STALEY CAPITAL ADVISERS, opening a new position worth an estimated $233K. The largest seller was Frontier Investment Management, exiting entirely with an estimated $2.29M sold.
- 8 institutional investors held Allergan Inc (AGN) as of Q2 2018, down from 9 in Q1 2018.
- Funds reported $11.1M of Allergan Inc stock for Q2 2018, down 15% quarter-over-quarter.
- 1 fund opened new Allergan Inc positions in Q2 2018 and 2 closed out, a net change of -1 holder.
- The largest Allergan Inc buyer in Q2 2018 was STALEY CAPITAL ADVISERS, an estimated $233K added.
- The largest Allergan Inc seller in Q2 2018 was Frontier Investment Management, an estimated $2.29M sold.
Based on aggregated 13F filings for Q2 2018.